Pay in 4 interest-free payments of $7.22 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
The gradual increase helps minimize potential gastrointestinal side effects and allows the body to adjust to the medication
Malpetti M, Joie R, Rabinovici GD
Understanding Semaglutide Semaglutide is an FDA-approved GLP-1 agonist, indicated for the chronic management of weight in adults with obesity, or those overweight with weight-related health conditions
Without insurance or a discount, GLP-1 agonists can cost a few hundred dollars to over $1,000 per month
A Note for Canadian Researchers Health Canada has not yet reviewed Retatrutide, as Eli Lilly has not submitted a New Drug Submission (NDS) for the Canadian market
US$ 20.27
US$ 24.89
US$ 22.08
US$ 22.77
US$ 23.55
US$ 20.70
US$ 23.26
